North America IoT Implantable Cardiac Devices Market Outlook (2022-2033)

The North America IoT implantable cardiac devices market size is expected to reach US$ 20,787.1 million by 2033 from US$ 5,163.2 million in 2024. The market is estimated to record a CAGR of 17.7% from 2025 to 2033.

Executive Summary and North America IoT Implantable Cardiac Devices Market Analysis:

The IoT implantable cardiac devices market in North America is experiencing significant growth driven by the rising incidence of cardiovascular diseases & arrhythmias, demand for real-time monitoring & early intervention, advancements in device miniaturization & battery life. The​‍​‌‍​‍‌​‍​‌‍​‍‌ North America IoT Implantable Cardiac Devices market is the most technologically advanced. It is well-supported by a substantial healthcare framework, rigorous regulatory processes, and a high rate of adoption of connected technologies. Among the United States and Canada, the United States is the major source of innovation with the widespread deployment of connected pacemakers, implantable defibrillators, and insertable cardiac monitors. Canada is gradually expanding the use of these devices through its universal healthcare system. In terms of technology, most of the devices are Bluetooth-enabled, as it is a low-cost technology, and these devices are getting mHealth applications-ready.

On the other hand, there are some cellular-enabled devices that are becoming popular. Hospitals and clinics are still the main end users of these devices and are assisted by specialized cardiac centers and a strong focus on preventive cardiology. Major multinational players are profoundly integrated, while regional innovators in Silicon Valley and Toronto are rapidly advancing with the development of cutting-edge IoT-localized solutions for meeting local demands. The most difficult issues are the reimbursement challenges, cybersecurity issues, and the need for interoperability among different healthcare systems. North America is in a strong position because of well-backed government healthcare initiatives, aging populations, and growing preventive cardiology awareness, despite all these challenges. This market analysis highlights that North America is shifting from conventional cardiac care towards the use of IoT-enabled solutions, which makes it a global leader in IoT implantable cardiac ​‍​‌‍​‍‌​‍​‌‍​‍‌devices.

North America IoT Implantable Cardiac Devices Market Segmentation Analysis

Key segments that contributed to the derivation of the IoT implantable cardiac devices market analysis are product, technology, application, and end user.

• By product, the IoT implantable cardiac devices market is segmented into IoT connected pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, cardiac resynchronization therapy devices, and others. IoT connected pacemakers dominated the market in 2024, driven by advanced adoption in U.S. and Canadian cardiac centers addressing aging populations.
• By technology, the IoT implantable cardiac devices market is segmented into Bluetooth, cellular, and others. Bluetooth dominated the market in 2024, driven by seamless integration with mobile health apps and widespread smartphone penetration.
• In terms of application, the market is segmented into arrhythmia detection, heart failure monitoring, remote pacemaker management, and others. The arrhythmia detection segment dominated the market in 2024, driven by a strong emphasis on preventive cardiology and large-scale screening programs.
• By end user, the market is segmented into hospitals & clinics, specialty cardiac centers, and others. Hospitals & clinics dominated the market in 2024, driven by the dominance of specialized hospital networks and advanced cardiac care infrastructure.

North America IoT Implantable Cardiac Devices Market Outlook

​‍​‌‍​‍‌​‍​The​‍​‌‍​‍‌​‍​‌‍​‍‌ expansion and adoption of digital health in the region will be major factors in the growth of the North America IoT Implantable Cardiac Devices market over the upcoming years. The main drivers of adoption will be healthcare reforms funded by the government, the expansion of telecom networks, and the increasing demand for remote monitoring. Although Bluetooth-enabled pacemakers are in a major trend, it is expected that cellular-enabled devices will become more popular as 5G infrastructure projects progress in the United States and Canada. Integration of IoT devices with national electronic health record systems will be the main goal of the strategic investments, thus facilitating monitoring in real-time and predictive analytics. Governments are supporting cardiovascular health with initiatives such as the U.S. Centers for Medicare & Medicaid Services' digital health programs and Canada's eHealth expansion, giving support to IoT integration. Proper implantation and monitoring will be ensured by training programs for healthcare professionals, which will become an indispensable part of the process. Demand will be driven by metropolitan areas such as New York, Los Angeles, Toronto, and Chicago, whereas rural areas will have to come up with new distribution models to meet demand. The forecast also points to the necessity of cybersecurity as regulators in North America require strong data protection measures for connected devices. Overall, North America is heading towards a market characterized mainly by connected ecosystems, predictive monitoring, and adoption strategies driven by the ​‍​‌‍​‍‌​‍​‌‍​‍‌government.

North America IoT Implantable Cardiac Devices Market Country Insights   

Based on country, the North America IoT implantable cardiac devices market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2024.

Insights​‍​‌‍​‍‌​‍​‌‍​‍‌ at the country level reflect that North America has three different adoption patterns. The United States is a leader with strong investments in digital health infrastructure and the extensive use of connected pacemakers. Canada is committed to universal healthcare, which is the main reason for the demand for IoT-enabled cardiac devices in both urban and rural areas. Mexico is smaller than its two northern neighbours, but it is slowly getting into IoT-enabled devices through partnerships with multinational players and healthcare modernization programs that are supported by the government. Local partnerships are very important. Major players are working with local distributors and healthcare providers to solve regulatory issues and ensure efficient supply. Success in the region will depend on adapting strategies to the local contexts, finding the right balance between affordability and innovation, and using partnerships to close the gaps in infrastructure and ​‍​‌‍​‍‌​‍​‌‍​‍‌expertise.

North America IoT Implantable Cardiac Devices Market Company Profiles

Medtronic Plc, GE HealthCare Technologies Inc, Koninklijke Philips NV, Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, Biotronik, MicroPort Scientific Corporation, LivaNova PLC, LEPU Medical Technology (Beijing) Co., Ltd., are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

North America IoT Implantable Cardiac Devices Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

North America IoT Implantable Cardiac Devices Key Sources Referred:

• World Health Organization (WHO)
• Organisation for Economic Cooperation and Development (OECD)
• The World Bank Group
• Worldometer
• The Lancet
• International Bar Association
• International Trade Administration
• Eurostat
• United Nations Department of Economic and Social Affairs